J&J steps up Tylenol production for COVID-19

16 April 2020 - Deborah Wilkes

Premium

Johnson & Johnson’s (J&J’s) OTC sales in the US increased by more than a third in the first quarter of 2020 amid the COVID-19 pandemic. Chairman and chief executive officer Alex Gorsky said the company had increased and refocused production of Tylenol (acetaminophen).

Click tags below for more information on topics:

Johnson & Johnson COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: